Motif Bio PLC Director/PDMR Shareholding (8270H)

TIDMMTFB

RNS Number : 8270H

Motif Bio PLC

22 August 2016

Motif Bio plc

("Motif Bio" or the "Company")

Notification and public disclosure of transactions by PDMR and persons closely associated with them

Motif Bio plc (AIM: MTFB), the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that on 22 August 2016 it was notified that Amphion Innovations plc ("Amphion") had pledged an additional 11,655,480 ordinary shares of 1 penny each in the capital of Motif Bio as security to a draw-down of an additional tranche of Amphion's loan facility (the "Share Pledge"). In total, Amphion has pledged 27,961,625 ordinary shares in the Company in relation to the Share Pledge. As a result of the Share Pledge, Amphion will transfer legal title to but will retain the beneficial interest in these pledged ordinary shares. Richard Morgan and Robert Bertoldi, non-executive Chairman and executive director of the Company respectively, are also directors of Amphion (the "Amphion Directors"). Amphion is therefore a "Person Closely Associated" with the Amphion Directors under the Market Abuse Regulation.

The Share Pledge does not change the number of ordinary shares of the Company in issue.

For further information please contact:

 
 Motif Bio plc                          [e-mail] 
 Graham Lumsden (Chief 
  Executive Officer) 
 
 Zeus Capital Limited 
  (NOMAD & BROKER)                    [phone] 
 Phil Walker/Giles Balleny 
 Dominic Wilson 
 
 Northland Capital Partners 
  Limited (BROKER)                    [phone] 
 Patrick Claridge/ David 
  Hignell 
 John Howes/ Rob Rees 
  (Broking) 
 
 Walbrook PR Ltd. (FINANCIAL      [phone] or 
  PR & IR)                        [e-mail] 
 Paul McManus                        Mob: [phone] 
                                                      893 
 Mike Wort                           Mob: [phone] 
                                                      002 
 
 MC Services AG (EUROPEAN 
  IR)                                  [phone] 
 Raimund Gabriel 
 
 
 
 1       Details of the person discharging managerial responsibilities/person 
          closely associated 
------  ----------------------------------------------------------------------- 
 a)      Name                              Amphion Innovations Plc 
------  --------------------------------  ------------------------------------- 
 2       Reason for the notification 
------  ----------------------------------------------------------------------- 
                                           Person Closely Associated with 
          Position/status                   PDMRs of Motif Bio Plc (Robert 
 a)                                         Bertoldi and Richard Morgan) 
------  --------------------------------  ------------------------------------- 
 b)      Initial notification/Amendment    Initial Notification 
------  --------------------------------  ------------------------------------- 
 3       Details of the issuer, emission allowance market 
          participant, auction platform, auctioneer or auction 
          monitor 
------  ----------------------------------------------------------------------- 
 a)      Name                              Motif Bio Plc 
------  --------------------------------  ------------------------------------- 
 b)      LEI                               N/A 
------  --------------------------------  ------------------------------------- 
 4       Details of the transaction(s): section to be repeated 
          for (i) each type of instrument; (ii) each type 
          of transaction; (iii) each date; and (iv) each 
          place where transactions have been conducted 
------  ----------------------------------------------------------------------- 
 a)      Description of the                Ordinary Shares 
          financial instrument, 
          type of instrument                ISIN GB00BVVT4H71 
 
          Identification code 
------  --------------------------------  ------------------------------------- 
 b)      Nature of the transaction         Transfer of the legal but not 
                                            beneficial interest in 11,655,480 
                                            Ordinary Shares by way of a pledge 
                                            for a loan 
------  --------------------------------  ------------------------------------- 
 c)      Price(s) and volume(s)             Price(s)    Volume(s) 
                                            ----------  ----------- 
                                             N/A         11,655,480 
                                            ----------  ----------- 
------  --------------------------------  ------------------------------------- 
 d)      Aggregated information             Price(s)    Volume(s) 
                                            ----------  ----------- 
                                             N/A         11,655,480 
                                            ----------  ----------- 
------  --------------------------------  ------------------------------------- 
 e)      Date of the transaction           22 August 2016 
------  --------------------------------  ------------------------------------- 
 f)      Place of the transaction          N/A 
------  --------------------------------  ------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEASPAADEKEFF

(END) Dow Jones Newswires

August 22, 2016 11:31 ET (15:31 GMT)